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AbsTrACT 
background early physical rehabilitation in the 
intensive care unit (icU) has been shown to improve 
short-term clinical outcomes but long-term benefit has 
not been proven and the optimum intensity of rehabilita-
tion is not known.
Methods We conducted a randomised, parallel-group, 
allocation-concealed, assessor-blinded, controlled trial in 
patients who had received at least 48 hours of invasive 
or non-invasive ventilation. Participants were randomised 
in a 1:1 ratio, stratified by admitting icU, admission 
type and level of independence. the intervention 
group had a target of 90 min physical rehabilitation 
per day, the control group a target of 30 min per day 
(both Monday to Friday). the primary outcome was the 
Physical component Summary (PcS) measure of SF-36 at 
6 months.
results We recruited 308 participants over 34 months: 
150 assigned to the intervention and 158 to the control 
group. the intervention group received a median (iQr) 
of 161 (67–273) min of physical rehabilitation on icU 
compared with 86 (31–139) min in the control group. at 
6 months, 62 participants in the intervention group and 
54 participants in the control group contributed primary 
outcome data. in the intervention group, 43 had died, 
11 had withdrawn and 34 were lost to follow-up, while 
in the control group, 56 had died, 5 had withdrawn and 
43 were lost to follow-up. there was no difference in the 
primary outcome at 6 months, mean (SD) PcS 37 (12.2) 
in the intervention group and 37 (11.3) in the control 
group.
Conclusions in this study, icU-based physical 
rehabilitation did not appear to improve physical 
outcomes at 6 months compared with standard physical 
rehabilitation.
Trial registration number iSrctn 20436833.
InTroduCTIon
It has been recognised for some time that phys-
ical and psychological recovery after a period 
of critical illness is slow and often incomplete. 
Current evidence informs us that patients report 
ongoing physical and psychological problems, and 
a decreased quality of life, for up to 5 years after 
their original illness.1 These problems start early, 
with muscle wasting occurring during the first week 
of critical illness and being more severe among 
those with multiple organ failure.2 The aetiology 
of critical illness neuromyopathy is multifactorial, 
with both direct (toxic) and indirect (immobility/
disuse atrophy) causes being implicated.3 Limiting 
the period of immobility and promoting movement 
and exercise are therefore intuitively attractive 
strategies to prevent muscle weakness and enhance 
recovery.
The concept of early mobilisation has developed 
in parallel with a better appreciation of the need 
to avoid over sedation, the importance of delirium 
and the value of spontaneous breathing trials.4 5 
However, there are few randomised controlled trials 
of interventions delivered in the intensive care unit 
(ICU) on which to base clinical practice. In 2009, a 
landmark trial by Schweickert and colleagues found 
that early physical and occupational therapy in 
mechanically ventilated patients in the medical ICU 
was safe and well tolerated, and resulted in better 
functional outcomes at hospital discharge, a shorter 
duration of delirium and more ventilator-free days 
compared with standard care.6 A recent multi-
centre trial in the surgical ICU also found that early, 
goal-directed mobilisation shortened patient length 
Key message
What is the key question?
Does an increased intensity of intensive care 
unit (ICU)-based physical rehabilitation therapy 
improve long-term physical quality of life 
compared with a standard intensity of physical 
rehabilitation as measured by the Physical Compo-
nent Summary (PCS) measure of SF-36?
What is the bottom line?
Delivering more ICU-based physical rehabilitation 
did not appear to improve physical outcomes at 
6 months but was limited by patient tolerance and 
a 5-day rehabilitation service.
Why read on?
The results of this trial of ICU-based physical reha-
bilitation therapy raise important questions about 
how early rehabilitation should be optimally deliv-
ered in the critically ill.
 Thorax Online First, published on August 5, 2017 as 10.1136/thoraxjnl-2016-209858
Copyright Article author (or their employer) 2017. Produced by BMJ Publishing Group Ltd (& BTS) under licence. 
group.bmj.com on January 8, 2018 - Published by http://thorax.bmj.com/Downloaded from 
2 Wright SE, et al. Thorax 2017;0:1–9. doi:10.1136/thoraxjnl-2016-209858
Critical care
of stay and improved patients’ functional mobility at hospital 
discharge.7
However, longer-term benefits have not yet been estab-
lished8–10 and systematic reviews have identified a need for 
large randomised controlled trials to further explore early 
mobilisation therapy, including longer-term outcomes and the 
ideal intensity and timing of exercise.11 12 Our hypothesis was 
that patients would report a sustained benefit in their physical 
health if they received more intensive physical rehabilitation in 
ICU compared with patients who received physical rehabilita-
tion typical of that provided at the time. In an attempt to test 
this hypothesis, we undertook a randomised controlled trial 
comparing the effects of two different intensities of early reha-
bilitation therapy—intensive versus standard—on the recovery 
of physical health-related quality of life at 6 months.
MeThods
study design
We conducted a randomised, parallel group, allocation-con-
cealed, assessor-blinded, controlled trial in mixed medical-sur-
gical ICUs of four hospitals in the UK. The trial had ethical 
approval from Newcastle and North Tyneside 2 Research 
Ethics Committee (11/NE/0206) and was registered (ISRCTN: 
20436833). A full trial protocol has been published.13
Participants
Patients were eligible for inclusion in the trial if they were aged 
18 years or older and had received 48 hours or more of either 
invasive or non-invasive ventilation. The original (and regis-
tered) version of the protocol listed 48–72 hours but the upper 
limit was removed 2 months into recruitment as the time window 
proved too narrow and eligible patients were being missed, 
especially at weekends. The exclusion criteria were as follows: 
end-of-life care; acute brain or spinal cord injury (or admitted 
following brain or spinal cord surgery); multiple trauma if 
mobilisation therapy was judged unlikely to be possible; burns; 
rapidly progressive neuromuscular disease; patients enrolled in 
another clinical trial without a co-enrolment agreement in place; 
and patients previously enrolled in this trial. Patients who had 
suffered a cardiac arrest could be recruited if the clinical team 
believed that there was a possibility of recovery. Patients were 
approached and written informed consent was obtained either 
from the patient or from a personal consultee, which was usually 
the next of kin.
randomisation and blinding
Participants were randomised, using a web-based randomisa-
tion system, in a 1:1 ratio, using permuted random block allo-
cation to either intervention or standard care group. Rando-
misation was stratified by admitting ICU, type of admission 
(surgical or medical) and the participant's prehospitalisation 
independence level using the Katz Index of independence in 
activities of daily living (0–3 was ‘low’, 4–6 was ‘high’). Owing 
to the nature of the intervention, it was not possible to mask 
the participants, research physiotherapists or the wider clinical 
team to the treatment group. Study outcomes at ICU discharge 
were assessed by the research physiotherapists (unblinded). 
Study outcomes at hospital discharge and at 3 and 6-month 
follow-up were assessed by research nurses who were blinded 
to the treatment group. To avoid accidental unblinding, the 
research nurses would ask the participants not to reveal their 
treatment group.
Procedures
All physical rehabilitation sessions were preceded by a sedation 
hold (or titration) with a target Richmond Agitation-Sedation 
Scale of −1, 0 or +1 and a safety screen.14 The physical rehabili-
tation therapy provided in the study included functional training 
and individually tailored exercise programmes.13 All physical 
rehabilitation therapy was provided by experienced critical care 
physiotherapists. The intervention group had a target delivery 
of 90 min of physical rehabilitation per day (Monday to Friday), 
split between at least two sessions. The standard care group had 
a target of 30 min of physical rehabilitation per day (Monday to 
Friday). Days when physical rehabilitation was able to be deliv-
ered were termed ‘treatment days’. The session was stopped 
immediately if the participant met any of the stopping criteria; 
otherwise, the session continued until either the target time was 
reached or the treating physiotherapist judged it appropriate to 
stop. The physical rehabilitation therapy received by the stan-
dard care group was the same as that provided normally in 
participating ICUs.15 Respiratory physiotherapy was given as 
standard in both groups.
The treating physiotherapists collected data on the time partic-
ipants were actively engaging with physical rehabilitation and 
the type of exercise/mobilisation completed; these times do not 
include the time required for session set-up and preparation, rest 
and recovery between exercises or passive range of movements. 
They also recorded the maximum strength demonstrated in 
both upper and lower limbs and/or the maximum mobility level 
reached during each session. Limb strength was measured using 
the Oxford Scale. The mobility levels achieved were defined as 
follows: (1) unable to sit supported; (2) able to sit supported; (3) 
able to sit out in a chair safely; (4) able to stand to transfer with 
support; (5) able to mobilise independently.13
Following discharge from ICU, both groups received routine 
ward-based physiotherapy and an exercise diary to continue 
independently on discharge from hospital. Any participant 
readmitted to ICU received standard physical rehabilitation 
during their first and any subsequent readmissions. Participants 
were followed until hospital discharge and invited to attend a 
follow-up at their hospital 3 and 6 months after randomisation. 
Follow-up questionnaires could be completed by telephone if 
participants were unable to attend in person.
outcomes
The primary outcome was the Physical Component Summary 
(PCS) measure of the 36 item Short Form survey (SF-36) (version 
2) Quality of Life questionnaire at 6 months.16 Secondary 
outcomes were as follows: the Mental Health Component 
Summary (MCS) measure of the SF-36; physical ability at ICU 
discharge (Modified Rivermead Mobility Index)17; length of 
ICU and hospital stay; exercise capacity (6 min walk test)18; 
functional status (Functional Independence Measure)19; hand 
grip strength; and survival status and place of residence at 3 and 
6 months following randomisation. The health economic eval-
uation used utility values derived from the EuroQol 5 dimen-
sion survey (EQ-5D)20 (administered at hospital discharge, 3 and 
6 months) and from the SF-36, using the algorithm provided by 
the SF-6D.21 Survival data up to 6 months were recorded for all 
participants from the Health & Social Care Information Centre.
statistical analysis
A sample size calculation based on a difference of five points in 
the primary outcome (PCS of SF-36), 80% power and a signif-
icance level of 0.05 required 77 patients to contribute primary 
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outcome data at 6 months. Allowing for a mortality rate of 40% 
and a further 10% loss to follow-up required 154 in each group 
(308 participants in total). We used univariate analysis to calcu-
late basic summary statistics and multiple linear regression to 
adjust for the effects of covariates, including stratification vari-
ables. Kaplan-Meier and the log-rank test were used to compare 
survival between the groups at ICU and hospital discharge as 
well as at 3 and 6 months. Cox proportional hazards models 
were used to compute unadjusted and adjusted HRs for overall 
survival. All analyses were performed on an intention-to-treat 
basis. A statistical analysis plan was written and agreed by the 
Trial Management Group before analysis of the study data. 
Statistical analysis was performed using STATA V. 14. Additional 
descriptive analysis of physiotherapy data (table 1) was carried 
out using Microsoft Excel by an external consultant overseen by 
the Trial Management Group.
The health economic analysis compared costs of both the 
standard care and intervention groups from the health service 
perspective as well as a societal perspective. Patient costs for 
hospital visits were assessed at 6 months using the Patient Costs 
Questionnaire.13 Utility scores were calculated from SF-6D 
derived from responses to SF-36 and EQ-5D collected at 3 and 
6 months after hospital discharge. For the purpose of calculating 
quality-adjusted life years (QALYs), baseline utility values were 
assumed to be the same value for all participants on admission 
to ICU. For each participant, we used the lowest possible value 
for SF-6D, the value for EQ-5D was based on a combination 
of responses to the questionnaire (mobility-3, selfcare-3, usual 
activities-3, pain/discomfort-2, anxiety-2) that was assumed to 
be appropriate for the average patient admitted to ICU. QALYs 
were calculated using the area under the curve method with 
three time points of baseline and 3 and 6 months.22
resulTs
Between 16 January 2012 and 4 December 2014, we enrolled 
308 participants, 150 were assigned to receive intensive and 158 
to receive standard physical rehabilitation therapy (figure 1). 
Sixteen participants withdrew consent, but all consented to the 
use of collected data. At 6 months, 62 (41%) participants in the 
intervention group and 54 (34%) participants in the standard 
care group contributed primary outcome data, a total of 116 of 
the 154 (75%) expected from the original sample size calcula-
tion. In the intervention group, 43 (29%) had died, 11 (7%) had 
withdrawn and 34 (23%) were lost to follow-up, while in the 
standard care group, 56 (35%) had died, 5 (3%) had withdrawn 
and 43 (27%) were lost to follow-up. Including participants 
who had withdrawn from the study in the denominator, primary 
outcome data were collected for 62 of 107 (58%) participants 
alive at 6 months in the intervention group, and 54 of 102 (53%) 
participants alive at 6 months in the standard care group.
The study groups had similar baseline characteristics (table 2) 
although the proportion of males in the intensive group (54%) 
was lower than in the standard care group (63%). The majority 
of participants in both groups were admitted to ICU as an emer-
gency rather than as planned postoperative admissions. Partici-
pants in both groups were divided equally between medical and 
surgical admissions, and had similar severity of illness scores. 
Prehospitalisation independence levels were high, with 135 
(93%) of the intensive group and 144 (93%) of the standard care 
group being functionally independent (Katz Index 6) at baseline. 
Before randomisation, participants in the intervention group 
had been on ICU for a median (IQR) of 6 (4–9) days compared 
with 5 (4–8) in the standard care group. Participants in both 
groups had been ventilated for a similar number of days before 
randomisation (median 4 days in both groups).
In the intensive group, physiotherapists attempted to deliver 
4079 physical rehabilitation sessions, of which a sedation hold 
(or titration) was judged safe and undertaken in 3579 (87.7%). 
Participants had a successful sedation hold (or titration), passed 
the safety screen and started physical rehabilitation in 2068 
(50.7%) sessions in the intensive group. In the standard care 
group, physiotherapists attempted to deliver 2515 physical reha-
bilitation sessions, of which a sedation hold (or titration) was 
judged safe and undertaken in 2141 (85.1%). Participants had 
a successful sedation hold (or titration), passed the safety screen 
and started physical rehabilitation in 1335 (53.1%) sessions in 
the standard care group.
Details of the physical rehabilitation sessions delivered in the 
two study groups are shown in table 1. At a participant level, the 
median (IQR) number of days from enrolment to the first day 
when physical rehabilitation was received (excluding passive range 
of movement exercises) was 3 (1–6) days in both groups. In total, 
the intervention group received a median (IQR) of 161 (67–273) 
min of physical rehabilitation on ICU compared with 86 (31–139) 
min in the standard care group. The majority of the extra time was 
given to strengthening exercises over functional retraining. Physical 
Table 1 Characteristics of physical rehabilitation delivered at group 
and participant level
Intensive
(n=150)
standard care 
(n=158)
Group-level data
  Physical rehabilitation sessions
   Functional retraining
   Strengthening
   Functional retraining and strengthening
   Total
757 (37%)
674 (33%)
637 (31%)
2068
488 (37%)
406 (30%)
441 (33%)
1335
  Physical rehabilitation time, min
   Functional retraining
   Strengthening
   Total time
15 032
12 317
27 349
9110
6269
15 379
Participant-level data
   Days from enrolment to first day when 
physical rehabilitation received
3 (1–6) 3 (1–6)
  Physical rehabilitation time in ICU (total received), min
   Functional retraining
   Strengthening
   Total time
86 (31–154)
72 (28–123)
161 (67–273)
45 (20–82)
24 (9–55)
86 (31–139)
   Physical rehabilitation sessions in ICU 10 (4–19) 6 (2–12)
   Percentage study days where physical 
rehabilitation received*
57 (34–77) 40 (17–54)
  Physical rehabilitation time per treatment day†, min
   Functional retraining
   Strengthening
   Total time
12 (8–17)
10 (6–15)
23 (16–28)
8 (5–10)
5 (2–8)
13 (10–17)
Data are n (%) or median (IQR).
*Study days are defined as the number of days between enrolment and the date 
the participant was recorded as being ready for discharge from ICU; if unavailable, 
the actual date of ICU discharge was used.
†Treatment days are defined as the number of days when the participant received 
physical rehabilitation on ICU; physical rehabilitation in either arm was only 
delivered Monday to Friday. Data are ‘median of means’, that is, a mean time was 
calculated for each participant and then, as the data were not normally distributed, 
a median (IQR) was calculated for each trial arm.
ICU, intensive care unit.
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rehabilitation was delivered on 57% of study days in the inter-
vention group and 40% of study days in the standard care group. 
Study days were defined as the number of calendar days between 
the date of enrolment and the date a participant was recorded as 
being ready for ICU discharge (if unavailable, the actual date of 
ICU discharge was used) and therefore include weekends, when no 
physical rehabilitation service was provided. On days when phys-
ical rehabilitation was able to be delivered (‘treatment days’), the 
intervention group received a median (IQR) of 23 (16–28) min of 
physical rehabilitation per day compared with 13 (10–17) min per 
day in the standard care group. The distribution of physical reha-
bilitation time delivered on treatment days differed between two 
groups (figure 2). The majority of treatment days in the standard 
care group included less than the target of 30 min physical rehabili-
tation, with 82% of treatment days including 20 min or less. In the 
intervention group, which had a target delivery of up to 90 min per 
day, the time delivered was more variable but only 8% of treatment 
days included greater than 45 min of physical rehabilitation.
Figure 1 Trial profile.
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The content of the individual physiotherapy sessions was 
broadly similar between groups, although a greater percentage 
of sessions included walking in the intervention arm (figure 3). 
With regard to limb strength, a greater proportion of sessions 
included exercises at Oxford Scale 4 or 5 in the intervention arm 
than in the standard care arm (figure 4). With regard to mobility, 
a greater proportion of sessions included mobilisation to levels 
3, 4 or 5 in the intervention arm than in the standard care group 
(figure 5).
The primary outcome measure, the mean (SD) PCS measure 
of the SF-36 at 6 months, was 37 (12.2) in the intervention group 
and 37 (11.3) in the standard care group with an adjusted differ-
ence in means −1.1 (95% CI −7.1 to 5.0). Secondary outcomes 
were also similar between groups across all follow-up time points 
(table 3 and online supplementary table S1). Only one secondary 
outcome, the Functional Independence Measure at 3 months, 
was significantly different between groups, although this should 
be interpreted with caution given the multiple tests. With regard 
to the loss to follow-up, there did not appear to be any differ-
ences in baseline characteristics between participants who were 
and those were not able to complete the primary outcome 
measure (online supplementary table S2). We undertook a post 
hoc analysis using multiple imputation for the primary outcome 
measure but the results were the same (online supplementary 
table S3). There was no significant difference in overall survival 
between groups at any time in the 6-month follow-up period 
(figure 6). This analysis was robust to adjusted and unadjusted 
Table 2 Characteristics of study participants at baseline
Intensive 
(n=150)
standard care 
(n=158)
  Age (years) 60 (16) 64 (16)
Sex
  Male
  Female
81 (54%)
69 (46%)
99 (63%)
59 (37%)
Type of admission
  Emergency
  Planned
134 (90%)
16 (10%)
143 (90%)
15 (10%)
Specialty
  Medical
  Surgical
78 (52%)
72 (48%)
82 (52%)
76 (48%)
  APACHE II score 19 (7) 19 (7)
  ICNARC Physiology Score 22 (8) 23 (9)
Premorbid Katz Index
  Low score (0–3)
  High score (4-6)
4 (3%)
141 (97%)
6 (4%)
149 (96%)
  ICU length of stay (days)* 6 (4–9) 5 (4–8)
  Duration of ventilation (days)* 4 (3–7) 4 (3–6)
Mode of ventilation
  Invasive
  Non-invasive
148 (99%)
1 (1%)
153 (98%)
4 (2%)
*ICU length of stay and duration of ventilation are at time of randomisation.
Data are n (%), mean (SD) or median (IQR).
APACHE, Acute Physiology and Chronic Health Evaluation; ICNARC, Intensive Care 
National Audit and Research Centre; ICU, intensive care unit.
Figure 2 Physical rehabilitation time delivered per treatment day. 
Treatment days are defined as the number of days when the participant 
received physical rehabilitation on intensive care unit.
Figure 3 Content of physical rehabilitation sessions.
Figure 4 Upper and lower limb strength achieved during physical 
rehabilitation sessions. Oxford Scale: 0/5 no contraction; 1/5 visible/
palpable muscle contraction but no movement; 2/5 movement with 
gravity eliminated; 3/5 movement against gravity only; 4/5 movement 
against gravity with some resistance; 5/5 movement against gravity 
with full resistance.
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Cox proportional hazards regression. By 6 months, most partic-
ipants had been discharged home, although seven in each group 
remained in hospital.
Results of the health economic analysis are shown in online 
supplementary table S4. Resource use during participants’ 
primary hospital admission was greater in the intervention 
group due to the increased physiotherapist time. Utility scores 
and QALYs were similar between groups.
One adverse event (AE) related to physical rehabilitation 
was reported during the study and occurred in the intervention 
group when a tracheostomy needed to be re-sited for a cuff leak. 
A second AE was reported in this group; however, on review this 
was found to have occurred well outside the relevant reporting 
time period. There were no serious AEs.
dIsCussIon
In this randomised controlled trial, a regime which provided 
more intensive physical rehabilitation in the critically ill did not 
confer any additional benefit over standard physical rehabili-
tation. We found no difference in either the primary outcome 
of self-reported physical health at 6 months or the secondary 
outcomes, including measures of functional ability and inde-
pendence, length of ICU and hospital stay, and mortality at 
6 months. Our results are similar to those of the two other 
randomised trials that included long-term assessments of phys-
ical function.9 23
This study has three main limitations. First, the absolute 
difference in the amount of physical rehabilitation received by 
participants in each arm of the trial was smaller than anticipated 
and possibly insufficient to produce a measurable difference in 
outcome.24 This was due to both the amount of physical reha-
bilitation received in the standard care group and factors that 
prevented more rehabilitation being delivered in the intensive 
group—the two principal reasons being a difficulty in achieving 
optimum levels of sedation (to allow rehabilitation to proceed 
safely) and participant fatigue. Most rehabilitation sessions ended 
due to participant fatigue, either at patient request or at the deci-
sion of the physiotherapist. Staff availability was not a major 
factor in understanding why the intervention was not delivered 
as intended as physiotherapists were available Monday to Friday. 
Second, we underestimated the difficulty in following up survi-
vors of critical illness beyond discharge from hospital; only 116 
of a planned 154 participants (75%) were able to contribute 
primary outcome data at 6 months. This proportion of loss to 
follow-up reduces the precision of the results and could intro-
duce bias, although the baseline characteristics of those who did 
and did not complete the SF-36 questionnaire at 6 months were 
similar. There is also a variable amount of missing data for the 
secondary outcomes as those completing follow-up by telephone 
were unable to complete the 6 min walk test and grip strength 
assessment. Third, it was not possible to blind participants, 
physiotherapists or other clinical staff to the intervention, which 
could have introduced bias.
This study also has several strengths. Compared with the 
existing literature it is relatively large; to our knowledge only 
the recent, single-centre trial by Morris and colleagues is of a 
similar size.25 Although the absolute difference between groups 
was smaller than anticipated, the intervention group did receive 
a more intensive physical rehabilitation regime than the standard 
care group. Despite the loss to follow-up, the majority of partic-
ipants underwent comprehensive assessments at ICU discharge, 
and we collected complete data for ICU and hospital length of 
stay and mortality to 6 months. Finally, the research staff under-
taking assessments at, and after, hospital discharge were blinded 
to the study group.
It is useful to compare our findings with those of the other 
published trials. An important study by Denehy et al9 was unable 
to show an improvement in outcome at 6 months, probably 
because the usual care group received a high level of physical 
mobilisation therapy.24 Participants in our standard care group 
received physical rehabilitation on 40% of study days, with 70% 
of rehabilitation sessions including active exercises, a greater 
intensity of physical rehabilitation than the ‘usual care’ recorded 
in other countries.26 27 On the other hand, participants in the 
intervention group received physical rehabilitation on 57% of 
study days an identical percentage to that reported in the inter-
vention group by Morris et al25 but less than that reported by 
others.23 28 Although physical rehabilitation times are not widely 
reported in other trials, the intervention group received a median 
(IQR) of 23 (16–28) min which is broadly comparable to the 
mean (SD) ‘session times’ of 31 (7) min in the study by Moss 
et al23 and the median (IQR) 20 (0–41) min of ‘active exercises’ 
received in a pilot study by Hodgson et al.28 The proportion of 
patients lost to follow-up at 6 months is similar to that reported 
by Moss et al23 at the same time point and also by Schaller et al 
at 3 months.7 Other trials, however, have achieved much better 
rates of follow-up to 6 months.9 28 29 Finally, a large proportion 
of screened patients were ineligible for the trial, most commonly 
because they had not received 48 hours or more of either inva-
sive or non-invasive ventilation, although other exclusion 
criteria applied. Because of the size of our trial, we chose eligi-
bility criteria aiming to include patients at high risk of physical 
impairment following discharge from ICU while excluding those 
who would be unlikely to benefit from the intervention. The 
result was a trial population which represented a relatively small 
subset of critically ill patients. The proportion of exclusions in 
other rehabilitation trials varies but the trial by Morris et al25 
also reported a high proportion of exclusions with 4804 patients 
screened for 300 patients randomised.
There are five other possible explanations for why our results 
did not support our hypothesis.
1. The patient population—which was heterogeneous, older, 
with a longer duration of mechanical ventilation—may have 
been predicted to have the worst levels of disability after 
critical illness and, on the whole, have been unresponsive 
to the intervention.30 The primary outcome measure, which 
showed wide variation within groups, was flat for the first 
3 months and increased slowly in both groups by 6 months. 
A very similar recovery trajectory was seen in a cohort study 
of patients recovering from severe acute pancreatitis31 and 
Figure 5 Mobility level achieved during physical rehabilitation 
sessions.
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in the RECOVER trial.29 In contrast, the recovery trajectory 
in a large cohort study of younger survivors with acute 
respiratory distress syndrome (ARDS) was more rapid, with 
an early improvement in the same PCS outcome measure.1
2. It is possible that the intervention was not started early enough 
and that muscle weakness was already well established.2 
The median (IQR) duration of ventilation at randomisation 
was 4 (3–7) days with a further 3 (1–6) days until the first 
physical rehabilitation was received, excluding passive range 
of movements. In our experience, these delays occurred 
for a number of reasons: we did not have the resources to 
recruit patients at weekends; the eligibility criteria required 
patients to received 48 hours or more of either invasive or 
non-invasive ventilation before randomisation, although 
we usually approached surrogate decision makers before 
this; and in patients who were recruited, many were too 
unstable to achieve the required level of sedation and pass 
the safety screen to begin physical rehabilitation. This 
timescale from ICU admission, to enrolment, to active 
rehabilitation is comparable to some studies,8 9 23 25 although 
other investigators have succeeded in delivering much earlier 
rehabilitation therapy.6 7 28 The results from previous studies 
are not consistent but it would appear that the trials which 
have managed to deliver very early mobilisation have found 
Table 3 Primary and secondary outcome measures
Intensive n=150 standard care n=158 difference*
Physical Component summary measure of sF-36
Hospital discharge n=76/116 34 (8.0) n=76/113 34 (9.0) −1.0 (−4.2 to 2.2)
3 months n=69/115 35 (10.8) n=69/109 34 (9.0) −1.4 (−5.9 to 3.0)
6 months n=62/107 37 (12.2) n=54/102 37 (11.3) −1.1 (−7.1 to 5.0)
Mental Component Summary measure of SF-36
Hospital discharge n=76/113 40 (13.2) n=76/113 39 (11.4) 1.3 (−3.4 to 6.0)
3 months n=69/115 47 (11.8) n=69/109 45 (12.3) 4.2 (−1.2 to 9.5)
6 months n=62/107 47 (15.0) n=54/102 48 (11.5) −0.4 (−6.5 to 5.7)
Modified Rivermead Mobility Index† 
ICU discharge n=112/124 19 (10) n=104/118 16 (10) 0.4 (−2.7 to 3.4)
ICU length of stay (median (IQR) days)
Participants alive at ICU 
discharge
n=124 13 (8–21) n=118 15 (8–23) 0.3 (−4.0 to 4.8)‡ 
Participants deceased at ICU 
discharge
n=26 10 (6–29) n=40 9 (4–14) 5.2 (−7.3 to 16.7)‡
Hospital length of stay (median (IQR) days)
Participants alive at hospital 
discharge
n=116 28 (19–56) n=113 28 (20–43) 4.1 (−6.5 to 15.3)‡
Participants deceased at 
hospital discharge
n=34 14 (6–31) n=45 9 (5–21) −5.0 (−29.2 to 14.7)‡
Six-minute walk test (median (IQR) in metres)
Hospital discharge n=49/116 195 (120–260) n=34/113 173 (123–274) −27.9 (−86.1 to 31.8)‡
3 months n=32/115 293 (124–444) n=27/109 255 (120–337) −6.3 (−125.8 to 107.3)‡
6 months n=28/107 374 (203–435) n=25/102 321 (197–400) 61.7 (−47.2 to 157.0)‡
Functional Independence Measure§
ICU discharge n=114/124 70 (27) n=107/118 64 (25) −0.6 (−7.1 to 8.3)
Hospital discharge n=83/116 113 (17) n=75/113 108 (20) 1.2 (−5.2 to 7.7)
3 months n=71/115 116 (19) n=67/109 111 (23) 9.7 (0.9 to 18.5)
6 months n=64/107 118 (17) n=51/102 117 (16) 3.7 (−5.4 to 12.7)
Grip strength
ICU discharge n=95/124 14 (9) n=89/118 15 (9) −0.6 (−3.3 to 2.1)
Hospital discharge n=60/116 19 (10) n=54/113 22 (14) −3.5 (−8.1 to 1.2)
3 months n=36/115 25 (16) n=31/109 24 (14) 1.8 (−6.7 to 10.3)
6 months n=31/107 29 (19) n=31/102 24 (16) −0.5 (−11.3 to 10.3)
*Adjusted difference in means (95% CI). Multiple linear regression models included stratification variables (unit, admission type and preadmission Katz Index) and baseline 
variables sex, mode of ventilation, specialty, age in years, body mass index, randomisation lag (time between admission to ICU and participant randomisation), duration of 
ventilation and ICNARC Physiology Score.
†Distribution was positively skewed so bootstrap sampling was used to estimate 95% CIs for adjusted difference in means.
‡The Functional Independence Measure rates patients on a scale of 1 (<25% independence; total assistance required) to 7 (100% independence) against 18 activities, giving a 
maximum score of 126.
§The Modified Rivermead Mobility Index rates patients on a scale of 0 (unable to perform) to 5 (independent) against eight physical tasks, giving a maximum score of 40.
ICNARC, Intensive Care National Audit and Research Centre; ICU, intensive care unit.
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improved outcomes up to hospital discharge,8 9 while trials 
which intervened later have found no significant effect. The 
exceptions to this observation are the trial by Burtin et al8 
which recruited patients from their fifth day in ICU and 
found improved physical outcomes at hospital discharge and 
the trial by Morris et al25 which recruited patients in a similar 
timescale to our trial and found improved physical outcomes 
at 6 months.
3. It is also possible that the intervention ended too soon and 
that any benefits gained on ICU were subsequently lost on 
the ward or following discharge from hospital; however, this 
is not supported by the results which show no difference in 
physical or functional scores at ICU discharge.
4. Our statistical analysis did not specifically deal with the 
competing risk of mortality, which was non-significantly 
higher in the standard care group at 3 and 6 months. 
Although unlikely to be an important source of bias, it is 
possible that an intervention which improves survival could 
lead to a number of survivors with a low health-related 
quality of life.
5. The PCS measure of the SF-36 may not have been sensitive 
to change as it includes scoring coefficients from all eight 
domains of the SF-36, including the negative-scoring 
coefficients ‘role-emotional’ and ‘emotional well-being’, 
which may not have been affected by the intervention.32
Further improvements in physical rehabilitation will require 
a better understanding of the different phenotypes of critical 
illness and their varying recovery trajectories. Rehabilitation 
may then be better tailored to the individual, with perhaps 
the most intensive therapy aimed at younger patients, with 
less comorbidity, who have seen the biggest loss in function 
compared with baseline. New technology may enable patients 
to tolerate more physical rehabilitation in a way that fits flexibly 
with their other needs. Future work is needed to explore the 
barriers and facilitators to patients attending follow-up appoint-
ments, as well as ongoing work to determine the best outcome 
measures for rehabilitation trials.
In conclusion, this study set out to test whether an increased 
intensity of physical rehabilitation above that already deliv-
ered as standard in our region could lead to improved long-
term patient outcomes. We were not assessing some physical 
rehabilitation versus no physical rehabilitation but rather 
‘intensive’ versus ‘usual care’, both of which included care 
delivered by specialist critical care physiotherapists 5 days a 
week. It proved more difficult than expected to increase the 
intensity of rehabilitation above this baseline, due to partic-
ipant fatigue and the inability to provide rehabilitation at 
weekends; this may have limited the impact of the interven-
tion. The loss to follow-up at 6 months may have introduced 
bias and limits the confidence in our findings. In this context, 
ICU-based physical rehabilitation did not appear to improve 
physical outcomes at 6 months compared with standard phys-
ical rehabilitation.
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